Quick Takeaways
- David Hallett has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $3,829,056.
- Recent insider filing activity is available below.
Insider Trading & Ownership of David Hallett
- Location
- Oxford, United Kingdom
- Summary
- The estimated net worth of David Hallett is at least $3,829,056 dollars as of 19 Feb 2026. David Hallett is the Chief Scientific Officer of RECURSION PHARMACEUTICALS, INC. and owns shares of RECURSION PHARMACEUTICALS, INC. (RXRX) stock worth about $3.83M.
- Signature
- /s/Jonathan Golightly, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David Hallett and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: RECURSION PHARMACEUTICALS, INC. ($3,829,056).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of David Hallett
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Chief Scientific Officer | $3,829,056 | 17 Feb 2026 |
Insider Transactions Reported by David Hallett:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.